These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23040132)
1. Effect of interpregnancy interval after a mifepristone-induced abortion on neonatal outcomes in subsequent pregnancy. Huo XX; Gao ES; Cheng YM; Luo L; Liang H; Huang GY; Miao MH; Yuan W Contraception; 2013 Jan; 87(1):38-44. PubMed ID: 23040132 [TBL] [Abstract][Full Text] [Related]
2. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy. Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190 [TBL] [Abstract][Full Text] [Related]
3. Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy. Chen A; Yuan W; Meirik O; Wang X; Wu SZ; Zhou L; Luo L; Gao E; Cheng Y Am J Epidemiol; 2004 Jul; 160(2):110-7. PubMed ID: 15234931 [TBL] [Abstract][Full Text] [Related]
4. Mifepristone-induced abortion and duration of third stage labour in a subsequent pregnancy. Miao MH; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W Paediatr Perinat Epidemiol; 2010 Mar; 24(2):125-30. PubMed ID: 20415767 [TBL] [Abstract][Full Text] [Related]
5. Mifepristone-induced abortion and placental complications in subsequent pregnancy. Zhu QX; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W Hum Reprod; 2009 Feb; 24(2):315-9. PubMed ID: 19054774 [TBL] [Abstract][Full Text] [Related]
6. Repeated medical abortions and the risk of preterm birth in the subsequent pregnancy. Liao H; Wei Q; Duan L; Ge J; Zhou Y; Zeng W Arch Gynecol Obstet; 2011 Sep; 284(3):579-86. PubMed ID: 20978775 [TBL] [Abstract][Full Text] [Related]
7. Interpregnancy interval after live birth or pregnancy termination and estimated risk of preterm birth: a retrospective cohort study. Shachar BZ; Mayo JA; Lyell DJ; Baer RJ; Jeliffe-Pawlowski LL; Stevenson DK; Shaw GM BJOG; 2016 Nov; 123(12):2009-2017. PubMed ID: 27405702 [TBL] [Abstract][Full Text] [Related]
8. Effect of Interpregnancy Interval on Adverse Perinatal Outcomes in Southern China: A Retrospective Cohort Study, 2000-2015. Zhang L; Shen S; He J; Chan F; Lu J; Li W; Wang P; Lam KBH; Mol BWJ; Yeung SLA; Xia H; Schooling CM; Qiu X Paediatr Perinat Epidemiol; 2018 Mar; 32(2):131-140. PubMed ID: 29293278 [TBL] [Abstract][Full Text] [Related]
9. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial. von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A; BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370 [TBL] [Abstract][Full Text] [Related]
10. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies? Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095 [TBL] [Abstract][Full Text] [Related]
11. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study. Avraham S; Gat I; Duvdevani NR; Haas J; Frenkel Y; Seidman DS Fertil Steril; 2012 Mar; 97(3):612-5. PubMed ID: 22265034 [TBL] [Abstract][Full Text] [Related]
12. Effect of interpregnancy interval on adverse perinatal outcomes--a national study. Grisaru-Granovsky S; Gordon ES; Haklai Z; Samueloff A; Schimmel MM Contraception; 2009 Dec; 80(6):512-8. PubMed ID: 19913144 [TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion. Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for surgical intervention of early medical abortion. Meaidi A; Friedrich S; Gerds TA; Lidegaard O Am J Obstet Gynecol; 2019 May; 220(5):478.e1-478.e15. PubMed ID: 30763542 [TBL] [Abstract][Full Text] [Related]
17. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study. Bernard N; Elefant E; Carlier P; Tebacher M; Barjhoux CE; Bos-Thompson MA; Amar E; Descotes J; Vial T BJOG; 2013 Apr; 120(5):568-74. PubMed ID: 23346916 [TBL] [Abstract][Full Text] [Related]
18. Relationship Between Interpregnancy Interval and Adverse Perinatal and Neonatal Outcomes in Northern Alberta. Chen I; Jhangri GS; Lacasse M; Kumar M; Chandra S J Obstet Gynaecol Can; 2015 Jul; 37(7):598-605. PubMed ID: 26366816 [TBL] [Abstract][Full Text] [Related]
19. Concurrent use of mifepristone and misoprostol for early medical abortion. Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491 [TBL] [Abstract][Full Text] [Related]
20. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC; BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]